➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

FARESTON Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Fareston, and when can generic versions of Fareston launch?

Fareston is a drug marketed by Kyowa Kirin and is included in one NDA.

The generic ingredient in FARESTON is toremifene citrate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.

US ANDA Litigation and Generic Entry Outlook for Fareston

A generic version of FARESTON was approved as toremifene citrate by RISING on December 4th, 2018.

  Start Trial

Drug patent expirations by year for FARESTON
Drug Prices for FARESTON

See drug prices for FARESTON

Recent Clinical Trials for FARESTON

Identify potential brand extensions & 505(b)(2) entrants

Harbin Medical UniversityPhase 3
The Third Affiliated Hospital of Nanchang UniversityPhase 3
First Affiliated Hospital of Chongqing Medical UniversityPhase 3

See all FARESTON clinical trials

Pharmacology for FARESTON

US Patents and Regulatory Information for FARESTON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kyowa Kirin FARESTON toremifene citrate TABLET;ORAL 020497-001 May 29, 1997 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.